title: Emerging treatment modalities for advanced pancreatic neuroendocrine tumors.
authors.affiliation: Department of Biomedical and Dental Sciences and of Morphological and Functional Images, University Hospital of Messina, 1 Via Consolare Valeria, 98125, Messina, Italy. alessandrosindoni@alice.it.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Sindoni
authors.affiliation: Department of Human Pathology, University Hospital of Messina, Messina, Italy.
authors.forename: Fausto
authors.initials: F
authors.lastname: Famà
authors.affiliation: Department of Human Pathology, University Hospital of Messina, Messina, Italy.
authors.forename: Maria
authors.initials: M
authors.lastname: Gioffre-Florio
authors.affiliation: Department of Biomedical and Dental Sciences and of Morphological and Functional Images, University Hospital of Messina, 1 Via Consolare Valeria, 98125, Messina, Italy.
authors.forename: Sergio
authors.initials: S
authors.lastname: Baldari
mesh_terms: D006801:Humans; D018358:Neuroendocrine Tumors / Q000628:therapy*; D015282:Octreotide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009942:Organometallic Compounds / Q000627:therapeutic use*; D010190:Pancreatic Neoplasms / Q000628:therapy*; D019275:Radiopharmaceuticals / Q000627:therapeutic use*; D018000:Receptors, Peptide
chemical_list: D009942:Organometallic Compounds; D019275:Radiopharmaceuticals; D018000:Receptors, Peptide; C447941:lutetium Lu 177 dotatate; D015282:Octreotide